Long-acting antiretroviral therapy
Abstract
Nanoformulations of cabotegravir prodrugs have been developed to prolong the pharmacokinetics of the antiretroviral agent. They can be present in the plasma of mice and non-human primates for a year following a single injection.
- Publication:
-
Nature Materials
- Pub Date:
- July 2020
- DOI:
- 10.1038/s41563-020-0731-7
- Bibcode:
- 2020NatMa..19..826S